Back to top

Tvardi Therapeutics Expands At-The-Market Equity Program

Tvardi Therapeutics ( ($TVRD) ) just unveiled an update. On May 1, 2026, Tvardi Therapeutics entered into a Capital on Demand Sales Agreement with ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Tvardi Therapeutics, Inc. (TVRD)